Filtered By:
Condition: Hay Fever
Drug: Flovent

This page shows you your search results in order of date.

Order by Relevance | Date

Total 47 results found since Jan 2013.

M052 motor tics, an unknown side effect of intranasal fluticasone
In this report, we describe a patient who developed motor tics and mood disturbances after initiating intranasal fluticasone propionate. This side effect is rarely described in the literature, however, is important to consider when initiating the medication in the pediatric population.
Source: Annals of Allergy, Asthma and Immunology - November 1, 2021 Category: Allergy & Immunology Authors: N. D'Silva, D. Lindsay Source Type: research

Triamcinolone Acetonide in the Treatment of Perennial Allergic Rhinitis: A post hoc Efficacy Analysis of a Phase III Study Performed in Russia
Conclusions: TAA produced effective and prolonged improvement of PAR symptoms over a 4-week treatment period.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - September 14, 2021 Category: Allergy & Immunology Source Type: research

Triamcinolone Acetonide in the Treatment of Perennial Allergic Rhinitis: A post hoc Analysis of Quality of Life during a Phase III Study
Conclusions: TAA is effective in improving overall and individual domains of QoL in patients with PAR, over 4 weeks. Patients with a previous diagnosis of allergic conjunctivitis experienced significant improvements in QoL related to the resolution of these symptoms.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - September 6, 2021 Category: Allergy & Immunology Source Type: research

MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review
Allergic rhinitis (AR) is prevalent, and many patients present with moderate-to-severe symptomatic disease. The majority of patients are not satisfied with their AR treatment, despite the use of concurrent medications. These gaps underscore the need for treatment with more effective options for moderate-to-severe AR. The authors ’ objective was to review systematically the efficacy and safety of MP-AzeFlu for the treatment of AR. The primary outcomes studied were nasal, ocular, and total symptoms. Other outcomes included time to onset and of AR control, quality of life, and safety. Searches of PubMed and Cochrane databas...
Source: International Archives of Allergy and Immunology - June 3, 2021 Category: Allergy & Immunology Source Type: research

Comparative Nasal Airflow with Loratadine-Pseudoephedrine and Fluticasone Nasal Spray for Allergic Rhinitis
CONCLUSION: A single dose of LP quickly and significantly improved nasal airflow after ragweed pollen challenge in an EEU. Comparatively, FP did not display this same benefit.PMID:34000435 | DOI:10.1016/j.anai.2021.05.001
Source: Annals of Allergy, Asthma and Immunology - May 17, 2021 Category: Allergy & Immunology Authors: Charlene C Ng Daniel Romaikin Lisa M Steacy David A Stevens Terry J Walker Daniel E Adams Anne K Ellis Source Type: research

Comparison Table: Some Nasal Sprays for Allergic Rhinitis (online only)
Date: April 19, 2021 Issue #:  1622Summary:  View the Comparison Table: Some Nasal Sprays for Allergic Rhinitis
Source: The Medical Letter - April 1, 2021 Category: Drugs & Pharmacology Authors: admin Tags: Allergic rhinitis Antihistamines azelastine azelastine/fluticasone propionate Beclomethasone Beconase AQ Budesonide ciclesonide Cromolyn Dymista Flonase Allergy Relief Flonase Sensimist Flunisolide fluticasone furoate Intranasa Source Type: research

A070 changes in nasal airflow with loratadine-pseudoephedrine versus fluticasone spray after first dose for allergy
Previous work shows fast onset for oral antihistamine/pseudoephedrine combination tablets and slower onset for intranasal steroid sprays. The purpose of this first head-to-head study was to evaluate nasal airflow changes produced by single doses of loratadine/pseudoephedrine tablet (LRT/PSE) and fluticasone propionate nasal spray (FS) in subjects with allergic rhinitis and nasal congestion by measuring changes in peak nasal inspiratory flow (PNIF).
Source: Annals of Allergy, Asthma and Immunology - November 1, 2020 Category: Allergy & Immunology Authors: C. Ng, D. Romaikin, L. Steacy, D. Stevens, A. Ellis Tags: Rhinitis, Other Upper Airway Disorders Source Type: research

Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study
Conclusion: MP-AzeFlu treatment reduced VAS severity and quality-of-life scores from baseline in the total population and ARPs, supporting MP-AzeFlu as an effective treatment for all patients with moderate-to-severe AR, regardless of AR phenotype or comorbidities.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - August 21, 2020 Category: Allergy & Immunology Source Type: research

Ocular Symptoms Improvement from Intranasal Triamcinolone compared with Placebo and Intranasal Fluticasone Propionate: a meta-analysis.
CONCLUSION: The meta-analysis demonstrated the positive clinical improvements TAA has on total ocular allergy symptoms, especially tearing, in addition to its recognized nasal symptom efficacy in SAR. PMID: 32004698 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - January 27, 2020 Category: Allergy & Immunology Authors: Bielory L, Gross G, Letierce A, Melas-Melt L, Lucio L Tags: Ann Allergy Asthma Immunol Source Type: research

Interaction between air pollution and pollen seasons on allergic rhinitis control
A few studies have suggested an interaction between air pollution and pollen exposure on allergy symptoms but more research is needed. As part of the POLLAR (Impact of Air Pollution in Asthma and Rhinitis) project, we investigated the associations between major air pollutants (ozone and PM2.5) and allergic rhinitis control, during grass and birch pollen seasons, using the Allergy Diary app (a validated mHealth tool for allergic rhinitis management). The daily impact of allergic symptoms was recorded, using visual analogue scale (VAS), by 3,328 geolocated app users in 2017 and 2018 in Northern Europe, representing 36,523 VA...
Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: Bedard, A., Bousquet, J., Anto, J. M., Garcia-Aymerich, J., Arnavielhe, S., Laune, D., Sofiev, M., Basagana, X. Tags: Occupational and environmental health Source Type: research

MP ‐AzeFlu provides rapid and effective allergic rhinitis control: results of a non‐interventional study in Denmark
ConclusionMP ‐AzeFlu provided effective, rapid, and sustained symptom control in a real‐life setting among patients from Denmark. These results align with EU and ARIA objectives and support the effectiveness of MP‐AzeFlu for the treatment of AR in real life.
Source: International Forum of Allergy and Rhinology - March 27, 2019 Category: Allergy & Immunology Authors: Peter A. Haahr, Claus Jacobsen, Maria E. Christensen Tags: ORIGINAL ARTICLE Source Type: research

Triamcinolone Acetonide versus Fluticasone Propionate in the Treatment of Perennial Allergic Rhinitis: A Randomized, Parallel-Group Trial
Conclusions: Triamcinolone acetonide proved to be non-inferior to fluticasone propionate in adult patients with PAR; both treatments decreased rTNSS values and showed a good safety profile.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - March 15, 2019 Category: Allergy & Immunology Source Type: research